Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Macrolones Are a Novel Class of Macrolide Antibiotics Active against Key Resistant Respiratory Pathogens In Vitro and In Vivo (CROSBI ID 230890)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Čipčić Paljetak, Hana ; Verbanac, Donatella ; Padovan, Jasna ; Dominis-Kramarić, Miroslava ; Kelnerić, Željko ; Banjanac, Mihailo ; Ergović, Gabrijela ; Simon, Nerrisa ; Broskey, John ; Holmes, David et al. Macrolones Are a Novel Class of Macrolide Antibiotics Active against Key Resistant Respiratory Pathogens In Vitro and In Vivo // Antimicrobial agents and chemotherapy, 60 (2016), 9; 5337-5348. doi: 10.1128/AAC.00524-16

Podaci o odgovornosti

Čipčić Paljetak, Hana ; Verbanac, Donatella ; Padovan, Jasna ; Dominis-Kramarić, Miroslava ; Kelnerić, Željko ; Banjanac, Mihailo ; Ergović, Gabrijela ; Simon, Nerrisa ; Broskey, John ; Holmes, David ; Eraković Haber, Vesna

engleski

Macrolones Are a Novel Class of Macrolide Antibiotics Active against Key Resistant Respiratory Pathogens In Vitro and In Vivo

As we face an alarming increase in bacterial resistance to current antibacterial chemotherapeutics, expanding the available therapeutic arsenal in the fight against resistant bacterial pathogens causing respiratory tract infections is of high importance. The antibacterial potency of macrolones, a novel class of macrolide antibiotics, against key respiratory pathogens was evaluated in vitro and in vivo. MIC values against Streptococcus pneumoniae, Streptococcus pyogenes, Staphylococcus aureus, and Haemophilus influenzae strains sensitive to macrolide antibiotics and with defined macrolide resistance mechanisms were determined. The propensity of macrolones to induce the expression of inducible erm genes was tested by the triple-disk method and incubation in the presence of subinhibitory concentrations of compounds. In vivo efficacy was assessed in a murine model of S. pneumoniae- induced pneumonia, and pharmacokinetic (PK) profiles in mice were determined. The in vitro antibacterial profiles of macrolones were superior to those of marketed macrolide antibiotics, including the ketolide telithromycin, and the compounds did not induce the expression of inducible erm genes. They acted as typical protein synthesis inhibitors in an Escherichia coli transcription/translation assay. Macrolones were characterized by low to moderate systemic clearance, a large volume of distribution, a long half-life, and low oral bioavailability. They were highly efficacious in a murine model of pneumonia after intraperitoneal application even against an S. pneumoniae strain with constitutive resistance to macrolide-lincosamide-streptogramin B antibiotics. Macrolones are the class of macrolide antibiotics with an outstanding antibacterial profile and reasonable PK parameters resulting in good in vivo efficacy.

macrolides ; quinolones ; antibiotic resistance ; pneumonia ; animal models ; antibacterial activity

Riječ je o izvornom znastvenom članku

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

60 (9)

2016.

5337-5348

objavljeno

0066-4804

10.1128/AAC.00524-16

Povezanost rada

Farmacija

Poveznice
Indeksiranost